首页 正文

Aprocitentan: a new emerging prospect in the pharmacotherapy of hypertension

{{output}}
Background: Resistant hypertension (RH) is linked to higher risks of cardiovascular events and there remains an unmet therapeutic need driven by pathophysiologic pathways unaddressed by guideline-recommended therapy. Whilst spiro... ...